Yao Wang Selected Research

Carcinoma (Carcinomatosis)

1/2024	Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma.
1/2022	Regulation of dietary polyphenols on cancer cell pyroptosis and the tumor immune microenvironment.
9/2020	Gemcitabine and checkpoint blockade exhibit synergistic anti-tumor effects in a model of murine lung carcinoma.
12/2018	Morin suppresses cachexia-induced muscle wasting by binding to ribosomal protein S10 in carcinoma cells.
1/2018	Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers.
1/2018	Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1α-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.
6/2017	B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma.
8/2015	Hyperglycemia Promotes Human Gastric Carcinoma Progression via Aquaporin 3.
9/2014	SPOP suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
6/2013	Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yao Wang Research Topics

Disease

236	Neoplasms (Cancer) 04/2024 - 01/2003
64	Infections 12/2023 - 10/2008
63	Inflammation (Inflammations) 07/2024 - 01/2003
35	Type 2 Diabetes Mellitus (MODY) 04/2024 - 04/2008
35	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2005
33	Neoplasm Metastasis (Metastasis) 11/2023 - 03/2003
26	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2011
22	Wounds and Injuries (Trauma) 03/2024 - 01/2003
22	Hypoxia (Hypoxemia) 01/2024 - 12/2011
21	COVID-19 11/2023 - 01/2020
19	Body Weight (Weight, Body) 04/2024 - 04/2008
18	Diabetes Mellitus 03/2024 - 11/2004
18	Obesity 01/2024 - 05/2008
18	Stroke (Strokes) 01/2024 - 05/2008
18	Insulin Resistance 01/2023 - 01/2015
17	Fibrosis (Cirrhosis) 03/2024 - 03/2013
17	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2010
16	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2016
16	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 10/2013
16	Myocardial Infarction 09/2022 - 11/2004
15	Acute Liver Failure (Fulminant Hepatic Failure) 02/2024 - 01/2018
15	Carcinogenesis 01/2024 - 08/2015
15	Carcinoma (Carcinomatosis) 01/2024 - 01/2003
15	Hypertension (High Blood Pressure) 12/2023 - 05/2008
15	Stomach Neoplasms (Stomach Cancer) 05/2023 - 04/2013
15	Coronary Artery Disease (Coronary Atherosclerosis) 03/2022 - 01/2012
14	Atherosclerosis 07/2024 - 09/2011
14	Pain (Aches) 05/2024 - 01/2017
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 12/2014
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2023 - 04/2011
14	Ischemic Stroke 04/2022 - 11/2009
14	Heart Failure 01/2022 - 01/2015
13	Sepsis (Septicemia) 04/2024 - 11/2010
12	Hyperglycemia 02/2024 - 05/2008
12	Cognitive Dysfunction 01/2024 - 01/2016
12	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 11/2011
11	Melanoma (Melanoma, Malignant) 04/2024 - 06/2007
11	Neuroinflammatory Diseases 03/2024 - 06/2018
11	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2010
10	Parkinson Disease (Parkinson's Disease) 04/2024 - 01/2015
10	Pre-Eclampsia (Preeclampsia) 01/2024 - 11/2017
10	Virus Diseases (Viral Diseases) 11/2023 - 07/2006
10	Colonic Neoplasms (Colon Cancer) 09/2022 - 07/2002
9	Hypertrophy 05/2024 - 06/2010
9	Necrosis 04/2024 - 10/2011
9	Diabetic Nephropathies (Diabetic Nephropathy) 01/2024 - 01/2017
9	Hemorrhage 12/2023 - 12/2014
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 01/2012
9	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 10/2010
9	Urinary Bladder Neoplasms (Bladder Cancer) 05/2023 - 01/2016
9	Graves Ophthalmopathy 01/2022 - 03/2014
8	Leukemia 01/2023 - 06/2010
8	Fever (Fevers) 08/2020 - 01/2013
8	Lymphatic Metastasis 01/2020 - 11/2007

Drug/Important Bio-Agent (IBA)

105	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2003
58	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
40	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 11/2004
40	CytokinesIBA 03/2024 - 06/2007
29	Long Noncoding RNAIBA 01/2024 - 05/2016
29	Chimeric Antigen ReceptorsIBA 11/2023 - 12/2014
23	LipidsIBA 07/2024 - 04/2008
22	MicroRNAs (MicroRNA)IBA 05/2024 - 11/2011
19	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2013
18	Interleukin-6 (Interleukin 6)IBA 04/2024 - 01/2016
18	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 05/2012
17	Messenger RNA (mRNA)IBA 12/2023 - 07/2005
16	Antiviral Agents (Antivirals)IBA 06/2023 - 07/2006
15	Therapeutic UsesIBA 03/2024 - 01/2012
14	LipopolysaccharidesIBA 05/2024 - 06/2018
14	Transcription Factors (Transcription Factor)IBA 04/2024 - 08/2012
14	LigandsIBA 03/2024 - 07/2005
14	AntibodiesIBA 01/2024 - 05/2008
14	Peptides (Polypeptides)IBA 05/2023 - 01/2012
13	AntigensIBA 11/2023 - 01/2013
13	AlbuminsIBA 01/2023 - 12/2012
13	Insulin (Novolin)FDA Link 01/2023 - 04/2008
12	Retinaldehyde (Retinal)IBA 03/2024 - 02/2015
12	Blood Glucose (Blood Sugar)IBA 09/2023 - 05/2008
11	CateninsIBA 01/2024 - 03/2016
11	EnzymesIBA 01/2024 - 06/2004
11	VaccinesIBA 08/2023 - 01/2018
10	InterferonsIBA 03/2024 - 01/2010
10	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 10/2008
10	Indicators and Reagents (Reagents)IBA 01/2024 - 02/2015
10	salicylhydroxamic acid (SHAM)IBA 01/2024 - 10/2013
10	AntioxidantsIBA 01/2024 - 01/2013
10	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 07/2012
9	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2016
9	AcidsIBA 12/2023 - 07/2005
8	Monoclonal AntibodiesIBA 11/2023 - 01/2010
8	Neuroprotective AgentsIBA 10/2023 - 01/2012
8	teprotumumabIBA 01/2022 - 01/2019
8	Interleukin-2 (IL2)IBA 02/2014 - 06/2007

Therapy/Procedure

142	Therapeutics 05/2024 - 07/2005
40	Drug Therapy (Chemotherapy) 01/2024 - 10/2010
29	Immunotherapy 03/2024 - 01/2010
13	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2023 - 12/2014
11	Aftercare (After-Treatment) 01/2024 - 01/2010
10	Radiotherapy 01/2023 - 06/2007
9	Electroacupuncture 04/2024 - 11/2019